AVTR

AVTR

USD

Avantor Inc. Common Stock

$12.870-0.330 (-2.500%)

Prix en Temps Réel

Healthcare
Medical Instruments & Supplies
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$13.200

Haut

$13.360

Bas

$12.725

Volume

1.13M

Fondamentaux de l'Entreprise

Capitalisation Boursière

8.8B

Industrie

Medical Instruments & Supplies

Pays

United States

Statistiques de Trading

Volume Moyen

10.13M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $12.195Actuel $12.870Haut $28

Actualités Connexes

PR Newswire

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

Voir plus
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference
Analyst Upgrades

Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14

Goldman Sachs analyst Matthew Sykes downgrades Avantor from Buy to Neutral and lowers the price target from $23 to $14.

Voir plus
Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14
Analyst Upgrades

RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20

RBC Capital analyst Conor McNamara maintains Avantor with a Outperform and lowers the price target from $24 to $20.

Voir plus
RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20
Analyst Upgrades

Stifel Downgrades Avantor to Hold, Lowers Price Target to $14

Stifel analyst Daniel Arias downgrades Avantor from Buy to Hold and lowers the price target from $26 to $14.

Voir plus
Stifel Downgrades Avantor to Hold, Lowers Price Target to $14
Analyst Upgrades

Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15

Morgan Stanley analyst Tejas Savant downgrades Avantor from Overweight to Equal-Weight and lowers the price target from $25 to $15.

Voir plus
Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15
Analyst Upgrades

Baird Maintains Outperform on Avantor, Lowers Price Target to $17

Baird analyst Catherine Schulte maintains Avantor with a Outperform and lowers the price target from $21 to $17.

Analyst Upgrades

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift

Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up.

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.